Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis

<div>IGF2BP3 expression in human colon cancer tissues. (a) Immunohistochemical staining of IGF2BP3 protein in colon cancer tissues and paracancer tissues; (b) quantitative analysis of IGF2BP3 mRNA.</div>

Disease Markers

fig9

Figure 9

Figure 9: Abnormal Expression of N6-Methyladenosine RNA Methylation Regulator IGF2BP3 in Colon Cancer Predicts a Poor Prognosis 